Evidence map›Paper›PMID 36450812›Full record

ArticleScientific reports2022

Pattern of SARS-CoV-2 variant B.1.1.519 emergence in Alaska.

Tracie J Haan, Lisa K Smith, Stephanie DeRonde, Elva House, Jacob Zidek, Diana Puhak, Matthew Redlinger, Jayme Parker, Brian M Barnes, Jason L Burkhead and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. A repeat pattern of founder events for SARS-CoV-2 variants in Alaska.medRxiv : the preprint server for health sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Tracie J HaanInstitute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK, USA.
Lisa K SmithAlaska Division of Public Health, State of Alaska, Fairbanks, AK, USA.
Stephanie DeRondeAlaska Division of Public Health, State of Alaska, Fairbanks, AK, USA.
Elva HouseAlaska Division of Public Health, State of Alaska, Fairbanks, AK, USA.
Jacob ZidekAlaska Division of Public Health, State of Alaska, Fairbanks, AK, USA.
Diana PuhakAlaska Division of Public Health, State of Alaska, Fairbanks, AK, USA.
Matthew RedlingerDepartment of Biological Sciences, University of Alaska Anchorage, Anchorage, AK, USA.
Jayme ParkerAlaska Division of Public Health, State of Alaska, Fairbanks, AK, USA.
Brian M BarnesInstitute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK, USA.
Jason L BurkheadDepartment of Biological Sciences, University of Alaska Anchorage, Anchorage, AK, USA.
Cindy KnallWWAMI School of Medical Education, University of Alaska Anchorage, Anchorage, AK, USA.
Eric BortzDepartment of Biological Sciences, University of Alaska Anchorage, Anchorage, AK, USA. ebortz@alaska.edu.
Jack ChenInstitute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK, USA. jchen15@alaska.edu.
Devin M DrownInstitute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK, USA. dmdrown@alaska.edu.
Alaska Department of Health and Social Services · USUniversity of Alaska Anchorage · USUniversity of Alaska Fairbanks · US

Funding

The Administrative CoreP20GM103395 · NIGMS · UNIVERSITY OF ALASKA FAIRBANKS · PI BRIAN M BARNES · 2012 to 2026
$66.1M
NIGMS NIH HHS P20 GM103395
6 · The paper itself

Abstract

Alaska has the lowest population density in the United States (US) with a mix of urban centers and isolated rural communities. Alaska's distinct population dynamics compared to the contiguous US may have contributed to unique patterns of SARS-CoV-2 variants observed in early 2021. Here we examined 2323 SARS-CoV-2 genomes from Alaska and 278,635 from the contiguous US collected from December 2020 through June 2021 because of the notable emergence and spread of lineage B.1.1.519 in Alaska. We found that B.1.1.519 was consistently detected from late January through June of 2021 in Alaska with a peak prevalence in April of 77.9% unlike the rest of the US at 4.6%. The earlier emergence of B.1.1.519 coincided with a later peak of Alpha (B.1.1.7) compared to the contiguous US. We also observed differences in variant composition over time between the two most populated regions of Alaska and a modest increase in COVID-19 cases during the peak incidence of B.1.1.519. However, it is difficult to disentangle how social dynamics conflated changes in COVID-19 during this time. We suggest that the viral characteristics, such as amino acid substitutions in the spike protein, likely contributed to the unique spread of B.1.1.519 in Alaska.

Indexed as

COVID-19SARS-CoV-2AlaskaAmino Acid SubstitutionHumans

Identifiers

PMID36450812
PMCPMC9712339
OpenAlexW4310388072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.